Does SELPERCATINIB Cause Hepatic function abnormal? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Hepatic function abnormal have been filed in association with SELPERCATINIB (RETEVMO). This represents 3.9% of all adverse event reports for SELPERCATINIB.
42
Reports of Hepatic function abnormal with SELPERCATINIB
3.9%
of all SELPERCATINIB reports
3
Deaths
21
Hospitalizations
How Dangerous Is Hepatic function abnormal From SELPERCATINIB?
Of the 42 reports, 3 (7.1%) resulted in death, 21 (50.0%) required hospitalization, and 2 (4.8%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SELPERCATINIB. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does SELPERCATINIB Cause?
Malignant neoplasm progression (106)
Death (90)
Hypertension (58)
Hypersensitivity (55)
Diarrhoea (54)
Fatigue (51)
Rash (49)
Alanine aminotransferase increased (38)
Pyrexia (38)
Aspartate aminotransferase increased (37)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which SELPERCATINIB Alternatives Have Lower Hepatic function abnormal Risk?
SELPERCATINIB vs SELUMETINIB
SELPERCATINIB vs SEMAGLUTIDE
SELPERCATINIB vs SEMUSTINE
SELPERCATINIB vs SENNA LEAF
SELPERCATINIB vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B